Literature DB >> 10347349

Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. The TIMI Study Group.

C M Gibson1, K A Ryan, M Kelley, M J Rizzo, R Mesley, S Murphy, J Swanson, S J Marble, J T Dodge, R P Giugliano, C P Cannon, E M Antman.   

Abstract

BACKGROUND: The Thrombolysis in Myocardial Infarction (TIMI) Study Group originally defined TIMI grade 3 flow (complete perfusion) as antegrade flow into the bed distal to the obstruction that occurs as promptly as antegrade flow into the bed proximal to the obstruction. Recently, several groups have defined TIMI grade 3 flow as opacification of the coronary artery within 3 cardiac cycles. METHODS AND
RESULTS: On the basis of heart rate data at the time of the cardiac catheterization and the time for dye to go down the artery (TIMI frame count/30 = seconds), we estimated the number of patients who would meet the 3 cardiac cycle criterion and compared this with the number of patients with TIMI grade 3 flow by using the original definition in 1157 patients from 3 recent TIMI trials (10 A, 10B, and 14). In 74 patients without acute myocardial infarction and normal coronary arteries, the fraction of a cardiac cycle required for dye to traverse the artery was a mean of 0.93 +/- 0.34 cardiac cycles (n = 74) (median 0.80, minimum 0.44, maximum 2.1, none >3.0 cycles). The mean heart rate at 90 minutes after thrombolysis in the TIMI 14 trial was 79.6 +/- 16.8 beats/min (n = 194), and the duration of 3 cardiac cycles was a mean of 2.36 seconds, or a TIMI frame count of 70.8 frames. In all trials, the rate of TIMI grade 3 flow was 57.3% (n = 663/1157) with the original definition and 66.8% (n = 743/1113) with the <3 cardiac cycle definition (P <.001).
CONCLUSIONS: A duration of 3 cardiac cycles for dye to traverse the artery lies approximately 6 SD above that observed in normal coronary arteries. A 3 cardiac cycle definition of TIMI grade 3 flow results in rates of normal perfusion that are approximately 10% higher than if the original definition of TIMI grade 3 flow is applied. Application of this simple correction factor may help place data reported with the 3 cardiac cycle definition of TIMI grade 3 flow in context.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10347349     DOI: 10.1016/s0002-8703(99)70380-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

Review 1.  Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests.

Authors:  Hernán Mejía-Rentería; Nina van der Hoeven; Tim P van de Hoef; Julius Heemelaar; Nicola Ryan; Amir Lerman; Niels van Royen; Javier Escaned
Journal:  Int J Cardiovasc Imaging       Date:  2017-05-13       Impact factor: 2.357

2.  Importance of the TIMI frame count: implications for future trials.

Authors:  Mark A Appleby; Andrew D Michaels; Michael Chen; C Gibson Michael
Journal:  Curr Control Trials Cardiovasc Med       Date:  2000

3.  B-type natriuretic peptide levels predict extent and severity of coronary artery disease in non-ST elevation acute coronary syndrome and normal left ventricular function.

Authors:  Brij Mohan Goyal; S M Sharma; Mohit Walia
Journal:  Indian Heart J       Date:  2013-12-26

4.  Influence of Tirofiban maintenance duration on patients with acute myocardial infarction treated by percutaneous coronary intervention.

Authors:  Zhen-Guo Ji; Hong-Bin Liu; Zhi-Hong Liu; Guo-Ping Ma; Li-Qiang Qin; Wei Dong; Li-Ya Wang
Journal:  Chronic Dis Transl Med       Date:  2015-07-06

5.  Predictive value of thrombolysis in myocardial infarction frame count for coronary microvascular dysfunction evaluated with an angiography-derived index of microcirculatory resistance in patients with coronary slow flow.

Authors:  Menghuan Li; Hu Su; Ming Jiang; Zhi Zuo; Zhenyang Su; Lijun Hao; Jiaming Yang; Zhiyong Zhang; Hui Wang; Xiangqing Kong
Journal:  Quant Imaging Med Surg       Date:  2022-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.